Close this search box.

Harnessing AI for Healthcare: A Multi-Faceted Approach by AstraZeneca at Cypher 2023

AstraZeneca experts discuss the transformative role of AI in healthcare, emphasizing ethical stewardship and innovation at Cypher 2023.

At Cypher 2023, a panel of experts from AstraZeneca delved into the transformative role of Artificial Intelligence (AI) in the healthcare sector. The panel consisted of Govind Rajith Cheramkalam, Director – Commercial Reporting and Analytics, Gopinath PR, Data Science Incubation Lead, Shobana Muthukrishnan, Senior Manager – GBS Advanced Analytics Solutions, and Dinesh Ramu, Brand Analytics Lead.

The Pharma Industry and AI

Govind Rajith Cheramkalam opened the discussion by highlighting the vast scope of AstraZeneca, a leading bio-pharmaceutical company. He emphasized that the company is not just about drug discovery but also about leveraging data science within the organization. He also touched upon the life cycle of a drug, which can take up to 20 years from molecule to medicine.

The Role of Analytics

Dinesh Ramu explained how analytics plays a crucial role in the pharmaceutical industry. From identifying the right professionals for drug discovery to targeting the right doctors for drug distribution, analytics is at the heart of these operations. He also mentioned that the data is analyzed to understand sales patterns, demographic distributions, and competitive landscapes.

Generative AI in Healthcare

Gopinath PR focused on the role of generative AI in healthcare. He discussed how large language models (LLMs) can be used to summarize vast amounts of data, making it easier for business users to gain insights. He also touched upon the use of retrieval-augmented generation (RAG) architecture to ensure data privacy and reduce hallucination in AI models.

The Future of Work in AI

Shobana Muthukrishnan spoke about the future of work with AI. She emphasized the need for ethical AI stewardship, especially in the healthcare sector. She also mentioned that as AI becomes a collaborative partner, it can help accelerate drug discovery, enhance quality assurance, and expedite regulatory processes.


The panel concluded that AI has the potential to revolutionize various aspects of the healthcare industry. From drug discovery and analytics to generative AI and ethical considerations, the scope is vast and transformative. As we move forward, the role of AI will only become more integral in healthcare, promising a future of innovation and ethical progress.

Picture of AIM Research
AIM Research
AIM Research is the world's leading media and analyst firm dedicated to advancements and innovations in Artificial Intelligence. Reach out to us at
Subscribe to our Latest Insights
By clicking the “Continue” button, you are agreeing to the AIM Media Terms of Use and Privacy Policy.
Recognitions & Lists
Discover, Apply, and Contribute on Noteworthy Awards and Surveys from AIM
AIM Leaders Council
An invitation-only forum of senior executives in the Data Science and AI industry.
Stay Current with our In-Depth Insights
The Biggest Exclusive Gathering Of CDOs & Analytics Leaders In United States

MachineCon 2024
26 July 2024, New York

MachineCon 2024
Meet 100 Most Influential AI Leaders in USA
Our Latest Reports on AI Industry
Supercharge your top goals and objectives to reach new heights of success!

Cutting Edge Analysis and Trends for USA's AI Industry

Subscribe to our Newsletter